Literature DB >> 26475250

Marker-based quantification of interfractional tumor position variation and the use of markers for setup verification in radiation therapy for esophageal cancer.

Peng Jin1, Astrid van der Horst2, Rianne de Jong2, Jeanin E van Hooft3, Martijn Kamphuis2, Niek van Wieringen2, Melanie Machiels2, Arjan Bel2, Maarten C C M Hulshof2, Tanja Alderliesten2.   

Abstract

PURPOSE: The aim of this study was to quantify interfractional esophageal tumor position variation using markers and investigate the use of markers for setup verification.
MATERIALS AND METHODS: Sixty-five markers placed in the tumor volumes of 24 esophageal cancer patients were identified in computed tomography (CT) and follow-up cone-beam CT. For each patient we calculated pairwise distances between markers over time to evaluate geometric tumor volume variation. We then quantified marker displacements relative to bony anatomy and estimated the variation of systematic (Σ) and random errors (σ). During bony anatomy-based setup verification, we visually inspected whether the markers were inside the planning target volume (PTV) and attempted marker-based registration.
RESULTS: Minor time trends with substantial fluctuations in pairwise distances implied tissue deformation. Overall, Σ(σ) in the left-right/cranial-caudal/anterior-posterior direction was 2.9(2.4)/4.1(2.4)/2.2(1.8) mm; for the proximal stomach, it was 5.4(4.3)/4.9(3.2)/1.9(2.4) mm. After bony anatomy-based setup correction, all markers were inside the PTV. However, due to large tissue deformation, marker-based registration was not feasible.
CONCLUSIONS: Generally, the interfractional position variation of esophageal tumors is more pronounced in the cranial-caudal direction and in the proximal stomach. Currently, marker-based setup verification is not feasible for clinical routine use, but markers can facilitate the setup verification by inspecting whether the PTV covers the tumor volume adequately.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Esophageal cancer; Fiducial markers; Interfractional position variation; Radiation therapy; Setup verification

Mesh:

Year:  2015        PMID: 26475250     DOI: 10.1016/j.radonc.2015.10.005

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

1.  Feasibility of a novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancer.

Authors:  Steen Riisgaard de Blanck; Jonas Scherman-Rydhög; Mette Siemsen; Merete Christensen; Lene Baeksgaard; Rasmus Irming Jølck; Lena Specht; Thomas Lars Andresen; Gitte Fredberg Persson
Journal:  Br J Radiol       Date:  2018-07-09       Impact factor: 3.039

2.  The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment.

Authors:  Melissa Thomas; Robin De Roover; Schalk van der Merwe; Maarten Lambrecht; Gilles Defraene; Karin Haustermans
Journal:  Clin Transl Radiat Oncol       Date:  2020-11-05

3.  Tailoring four-dimensional cone-beam CT acquisition settings for fiducial marker-based image guidance in radiation therapy.

Authors:  Peng Jin; Niek van Wieringen; Maarten C C M Hulshof; Arjan Bel; Tanja Alderliesten
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-12

4.  Comparison of carina-based versus bony anatomy-based registration for setup verification in esophageal cancer radiotherapy.

Authors:  Mélanie Machiels; Peng Jin; Christianne H van Gurp; Jeanin E van Hooft; Tanja Alderliesten; Maarten C C M Hulshof
Journal:  Radiat Oncol       Date:  2018-03-21       Impact factor: 3.481

5.  Quantifying esophageal motion during free-breathing and breath-hold using fiducial markers in patients with early-stage esophageal cancer.

Authors:  Yoshiko Doi; Yuji Murakami; Nobuki Imano; Yuki Takeuchi; Ippei Takahashi; Ikuno Nishibuchi; Tomoki Kimura; Yasushi Nagata
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

6.  Evaluation of a Novel Liquid Fiducial Marker, BioXmark®, for Small Animal Image-Guided Radiotherapy Applications.

Authors:  Kathryn H Brown; Mihaela Ghita; Giuseppe Schettino; Kevin M Prise; Karl T Butterworth
Journal:  Cancers (Basel)       Date:  2020-05-18       Impact factor: 6.639

7.  Measuring distance from the incisors to the esophageal cancer by FDG PET/CT: endoscopy as the reference.

Authors:  Szu-Wei Hsu; Jeffrey S Chang; Wei-Lun Chang; Forn-Chia Lin; Nan-Tsing Chiu
Journal:  BMC Gastroenterol       Date:  2022-03-17       Impact factor: 3.067

8.  Cone-Beam CT-based position verification for oesophageal cancer: Evaluation of registration methods and anatomical changes during radiotherapy.

Authors:  A van Nunen; M J C van der Sangen; M van Boxtel; P M A van Haaren
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2017-09-23

9.  Assessment and validation of the internal gross tumour volume of gastroesophageal junction cancer during simultaneous integrated boost radiotherapy.

Authors:  Jinming Shi; Yuan Tang; Ning Li; Yongwen Song; Shulian Wang; Yueping Liu; Hui Fang; Ningning Lu; Yu Tang; Shunan Qi; Bo Chen; Yexiong Li; Wenyang Liu; Jing Jin
Journal:  Radiat Oncol       Date:  2022-02-03       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.